Summary
A series of 55 patients with ruptured cerebral aneurysms were treated with moderate removal of subarachnoid clot followed by intracranial irrigation with pH 8.0 Hartmann solution containing 1 mg/ml of methylpredonizolone sodium succinate after the aneurysmal clipping during early (before day 3) operation. Six (11%) of the 55 patients suffered vasospasm syndrome postoperatively. The clinical results are significantly better than a series of 68 patients operated on and treated before day 3 by intracranial irrigation with Hartmann solution (pH 8.0) only. The possible preventive effect of direct intracranial administration of steroid hormone is discussed.
Similar content being viewed by others
References
Chyatte D, Rusch N, Sundt TM Jr (1983) Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methylpredonisolone. J Neurosurg 59: 925–932
Chyatte D, Fode NC, Nichols DA, Sundt TM Jr (1987) Preliminary report: Effects of high dose methylpredonisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 21: 157–160
Espinosa F, Weir B, Shnitka T (1986) Electron microscopy of simian cerebral arteries after subarachnoid hemorrhage and after the injection of horseradish peroxidase. Neurosurgery 19: 935–945
Findlay JM, Weir BKA, Kassell NF, Disney LB, Grace MGA (1991) Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 181–188
Flamm ES (1989) The potential use of nicardipine in cerebrovascular disease. Am Heart J 117: 236–242
Fox JL, Yasargil MG (1975) The relief of intracranial vasospasm: An experimental study with methylpredonisolone and cortisol. Surg Neurol 3: 214–218
Gilsbach JM, Harders AG (1989) Morbidity and mortality after early aneurysm surgery — a prospective study with nimodipine prevention. Acta Neurochir (Wien) 96: 1–7
Hashi K, Matsuoka Y, Tanaka K, Ohkawa N (1980) Treatment of cerebral vasospasm with large dose of hydrocortisone. In: Wilkins RH (ed) Cerebral arterial spasm. Williams and Wilkins, Baltimore, pp611–618
Hashi K, Takakura K, Sano K, Ohta T, Saito I, Okada K (1988) Intravenous hydrocortisone in large doses for the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage — results of a multi-center controlled double-blind clinical study. No To Shinkei (Tokyo) 40: 373–382
Kimura M, Suzuki S, Iwabuchi T (1989) The role of subarachnoid periarterial acidosis and platelets aggregation in symptomatic cerebral vasospasm: an experimental study. No Shinkei Geka (Tokyo) 17: 525–531
Kodama N, Sasaki T, Yamanobe K, Sato M (1988) Prevention of vasospasm; Cisternal irrigation therapy with urokinase and ascorbic acid. In: Wilkins RH (ed) Cerebral vasospasm. Raven, New York, pp415–418
Kusajima K, Wax SD, Webb WR (1974) Effects of methylpredonisolon on pulmonary microcirculation. Surg Gynecol Obstet 13: 1–5
Liszczak TM, Varsos VG, Black PM, Kistler JP, Zervas NT (1983) Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. J Neurosurg 58: 18–26
Mizoi K, Yoshimoto T, Fujiwara S, Sugawara T, Takahashi A (1991) Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator. Neurosurgery 28: 807–813
Mizukami M, Kawase T, Usami T, Tazawa T (1982) Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 10: 301–307
Ogane K, Suzuki S, Ohkuma H, Iwabuchi T (1982) Adventitial hyperpermeability after subarachnoid hemorrhage, and its prevention with intrathecal steroid administration in rats. Proceedings of 8th Symposium of Cerebral Vasospasm Tokyo. Cerebral Vasospasm 8: 245–251
Qhman J, Servo A, Heiskanen O (1991) Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 197–201
Ohta T, Kuroiwa T, Shimizu K, Shiguma M, Yamada K, Yasuda A, Sato G (1988) Exaggerated permeability via the adventitia of the spastic vessel wall in experimental cerebral vasospasm. In: Wilkins RH (ed) Cerebral vasospasm. Raven, New York, pp219–230
Ohta T, Kikuchi H, Hashi K, Kudo Y (1986) Nizofenone administration in the acute stage following subarachnoid hemorrhage. J Neurosurg 64: 420–426
Ohta T, Satoh G, Kuroiwa T (1992) The permeability change of major cerebral arteries in experimental vasospasm. Neurosurgery 30: 331–336
Petruk K, West M, Mohr G, Weir BKA, Benoit BG, Gentili F, Disney LB, Khan MI, Grace M, Holness RO, Karwon MS, Ford RM, Cameron GS, Tucker WS, Purves GB, Miller JDR, Hunter KM, Richard MT, Durity FA, Chan R, Clein LJ, Maroun FB, Godon A (1988) Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68: 505–517
Saito I, Sano K (1977) Significance of vasospasm in the treatment of ruptured intracranial aneurysms. J Neurosurg 47: 412–429
Sato J, Sato O, Kamitani H, Kanazawa I, Kokunai T (1979) Intracranial surgery and postoperative management of patients with ruptured aneurysm in acute and subacute stage — basal cisternal drainage and lumbar subarachnoid drainage. Neurol Med Chir (Tokyo) 19: 173–179
Sonobe M, Takahashi S, Koshu S, Hirota S (1988) Prevention of intracranial arterial vasospasm using combined ventriculocisternal shunting and cisternal drainage. In: Wilkins RH (ed) Cerebral vasospasm. Raven, New York, pp409–414
Souma M, Suzuki S, Nonogaki Y, Ohkuma H, Kimura M, Iwabuchi T (1989) The role of subarachnoid periarterial acidosis in symptomatic crebral vasospasm — a clinical study. Hirosaki Med J 41: 378–385
Sohma M, Suzuki S, Kimura M, Ohkuma H, Nonogaki Y, Iwabuchi T (1991) Adventitial hyperpermeability of cerebral artery in pathophysiology of cerebral vasospasm. Cerebrovascular Disease Tohoku 13: 83–87
Suzuki J, Yoshimoto T, Onuma T (1979) Early operations for ruptured intracranial aneurysms — study of 31 cases operated on within the first four days after ruptured aneurysms. Neurol Med Chir (Tokyo) 18 (I): 83–89
Suzuki S, Sobata E, Ando A, Iwabuchi T (1981) Anaerobic change of bloody CSF in subarachnoid haemorrhage. Its relation to cerebral vasospasm. Acta Neurochir (Wien) 58: 15–26
Suzuki S, Ohkuma H, Iwabuchi T, Yoshimura N (1988) Cerebral microthrombosis, synthesis imbalance of TXA2-PGI2, and subarachnoid focal acidosis in the pathogenesis of symptomatic cerebral vasospasm. In: Suzuki J (ed) Advances for cerebral stroke. Springer, Berlin Heidelberg New York Tokyo, pp405–410
Suzuki S, Sano K, Handa H, Asano T, Tamura A, Yonekawa Y, Ono H, Tachibana N, Hanaoka K (1989) Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study. Neurol Res 11: 79–88
Uemura Y, Okamoto Sh, Handa Y, Handa H (1987) Disturbance in the intramural circulation of the major cerebro-pial arteries after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 89: 71–76
Yamakawa K, Sasaki T, Tsubaki S, Nakagomi T, Saito I, Takakura K (1991) Effect of high-dose methylpredonisolone on vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 31: 24–31
Yoshida Y, Hayashi T, Amoh M, Ahagon A, Kusuno K, Uno T, Ogino T, Kobayashi H, Shibata N, Ueki S (1983) Postoperative intrathecal irrigation with plasminogen activator (urokinase) after early stage operation on ruptured cerebral aneurysm. Neurol Med Chir (Tokyo) 23: 659–666
Zabramski JM, Spetzler RF, Lee KS, Zimmerman RS, Bederson JB (1991) Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 189–196
Zervas NT, Liszczak TM, Mayberg MR, Black PM (1982) Cerebrospinal fluid may nourisch cerebral vessels through pathway in the adventitia that may be analogous to systemic vasa vasorum. J Neurosurg 56: 475–481
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, S., Ogane, K., Souma, M. et al. Efficacy of steroid hormone in solution for intracranial irrigation during aneurysmal surgery for prevention of the vasospasm syndrome. Acta neurochir 131, 184–188 (1994). https://doi.org/10.1007/BF01808610
Issue Date:
DOI: https://doi.org/10.1007/BF01808610